Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Westerly, G. Johnson, F. Maldonado, J. Utz, U. Specks, T. Peikert (Rochester, United States Of America). B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis. Eur Respir J 2014; 44: Suppl. 58, 4636

Member's Comments

No comment yet.

Related content which might interest you: Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases Source: International Congress 2016 – Orphan diseases II Year: 2016 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience Source: International Congress 2014 – ILDs 2 Year: 2014 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Familial pulmonary fibrosis: Clinical-functional and radiological features Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013